Loading provider…
Loading provider…
Internal Medicine Physician in Orlando, FL
NPI: 1225019284Primary Practice Location
ORLANDO HEALTH
92 W Miller St, Orlando, FL
Primary Employer
Orlando Health Medical Group Inc
orlandohealth.com
HQ Phone
Get MD Kwabena's Phone NumberMobile
Get MD Kwabena's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2003 - 2027
VA State Medical License
2001 - 2014
DC State Medical License
2001 - 2013
MD State Medical License
2000 - 2004

American Board of Internal Medicine
Internal Medicine
Providence Hospital
Residency • Internal Medicine
1998 - 2000
Saint Elizabeths Hospital-DC Department of Behavioral Health
Residency • Psychiatry
1996 - 1998
Karlovy University FOM
Medical School
Until 1982
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 135 | 446 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 105 | 304 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 94 | 94 |
| 4 | 99239Hospital discharge day management, more than 30 minutes | 71 | 71 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 40 | 40 |
Authors: Bordon, Jose, Master, Ronald N, Clark, Richard B, Duvvuri, Padmaraj, Karlowsky, James A, Ayesu, Kwabena, Klotchko, Alena, Kapoor, Rama, Ramirez, Julio
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia.
Authors: Juan Guardiola, Raul Nakamatsu, Alena Klochko
Journal: Int J Tuberc Lung Dis
Lead Sponsor: Seres Therapeutics, Inc.
Collaborators: Syneos Health
Intervention / Treatment: DRUG: Placebo, DRUG: SER-109
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib
Lead Sponsor: CSL Behring
Intervention / Treatment: DRUG: Placebo, DRUG: human immunoglobulin G